1. Home
  2. VATE vs ICCC Comparison

VATE vs ICCC Comparison

Compare VATE & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • ICCC
  • Stock Information
  • Founded
  • VATE 1994
  • ICCC 1982
  • Country
  • VATE United States
  • ICCC United States
  • Employees
  • VATE N/A
  • ICCC N/A
  • Industry
  • VATE Metal Fabrications
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • VATE Industrials
  • ICCC Health Care
  • Exchange
  • VATE Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • VATE 63.2M
  • ICCC 60.1M
  • IPO Year
  • VATE 1996
  • ICCC 1987
  • Fundamental
  • Price
  • VATE $4.69
  • ICCC $6.10
  • Analyst Decision
  • VATE
  • ICCC
  • Analyst Count
  • VATE 0
  • ICCC 0
  • Target Price
  • VATE N/A
  • ICCC N/A
  • AVG Volume (30 Days)
  • VATE 29.1K
  • ICCC 14.7K
  • Earning Date
  • VATE 08-05-2025
  • ICCC 08-14-2025
  • Dividend Yield
  • VATE N/A
  • ICCC N/A
  • EPS Growth
  • VATE N/A
  • ICCC N/A
  • EPS
  • VATE N/A
  • ICCC 0.20
  • Revenue
  • VATE $995,000,000.00
  • ICCC $28,274,756.00
  • Revenue This Year
  • VATE N/A
  • ICCC N/A
  • Revenue Next Year
  • VATE N/A
  • ICCC N/A
  • P/E Ratio
  • VATE N/A
  • ICCC $30.42
  • Revenue Growth
  • VATE N/A
  • ICCC 21.75
  • 52 Week Low
  • VATE $3.25
  • ICCC $3.34
  • 52 Week High
  • VATE $13.79
  • ICCC $7.60
  • Technical
  • Relative Strength Index (RSI)
  • VATE 41.27
  • ICCC 42.37
  • Support Level
  • VATE $4.40
  • ICCC $5.99
  • Resistance Level
  • VATE $5.21
  • ICCC $6.90
  • Average True Range (ATR)
  • VATE 0.57
  • ICCC 0.43
  • MACD
  • VATE -0.09
  • ICCC -0.00
  • Stochastic Oscillator
  • VATE 11.89
  • ICCC 13.51

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: